Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma.
David G SuDijana DjureinovicDavid A SchoenfeldBernadette Marquez-NostraKelly OlinoLucia JilaveanuHarriet M KlugerPublished in: JCO precision oncology (2024)
Our data suggest that MC1R might be a valuable drug target in aggressive melanoma. Additional studies are warranted to determine its functional significance in melanoma progression and its utility as a predictive biomarker in patients receiving MC1R-directed therapies.